DENTSPLY SIRONA Inc (NASDAQ:XRAY) Shares Sold by Texas Permanent School Fund

Texas Permanent School Fund lessened its stake in shares of DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 7.5% in the third quarter, according to its most recent filing with the SEC. The fund owned 41,760 shares of the medical instruments supplier’s stock after selling 3,363 shares during the period. Texas Permanent School Fund’s holdings in DENTSPLY SIRONA were worth $2,226,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in the company. First Trust Advisors LP lifted its holdings in shares of DENTSPLY SIRONA by 203.9% in the first quarter. First Trust Advisors LP now owns 91,083 shares of the medical instruments supplier’s stock valued at $4,517,000 after purchasing an additional 61,111 shares in the last quarter. Amundi Pioneer Asset Management Inc. lifted its holdings in shares of DENTSPLY SIRONA by 39.9% in the first quarter. Amundi Pioneer Asset Management Inc. now owns 184,628 shares of the medical instruments supplier’s stock valued at $9,157,000 after purchasing an additional 52,645 shares in the last quarter. Contravisory Investment Management Inc. purchased a new stake in shares of DENTSPLY SIRONA in the second quarter valued at $375,000. Retirement Systems of Alabama lifted its holdings in shares of DENTSPLY SIRONA by 5.3% in the second quarter. Retirement Systems of Alabama now owns 109,118 shares of the medical instruments supplier’s stock valued at $6,368,000 after purchasing an additional 5,490 shares in the last quarter. Finally, Douglass Winthrop Advisors LLC purchased a new stake in shares of DENTSPLY SIRONA in the second quarter valued at $412,000. Institutional investors own 93.46% of the company’s stock.

NASDAQ XRAY opened at $57.42 on Friday. DENTSPLY SIRONA Inc has a 1-year low of $34.93 and a 1-year high of $60.15. The company has a current ratio of 2.08, a quick ratio of 1.39 and a debt-to-equity ratio of 0.30. The company has a market capitalization of $12.31 billion, a PE ratio of 28.57, a price-to-earnings-growth ratio of 1.97 and a beta of 0.96. The firm’s fifty day simple moving average is $53.88 and its 200-day simple moving average is $54.19.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.57 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.50 by $0.07. The firm had revenue of $962.10 million for the quarter, compared to the consensus estimate of $940.38 million. DENTSPLY SIRONA had a net margin of 2.67% and a return on equity of 9.19%. The business’s quarterly revenue was up 3.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.38 earnings per share. As a group, analysts predict that DENTSPLY SIRONA Inc will post 2.39 EPS for the current year.

A number of research firms have recently weighed in on XRAY. Barrington Research reaffirmed a “buy” rating and issued a $63.00 price target on shares of DENTSPLY SIRONA in a research note on Monday, August 5th. Evercore ISI began coverage on shares of DENTSPLY SIRONA in a research note on Friday, July 26th. They issued an “in-line” rating on the stock. BidaskClub raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research note on Saturday. Stifel Nicolaus upped their price target on shares of DENTSPLY SIRONA from $61.00 to $63.00 and gave the stock a “buy” rating in a research note on Friday. Finally, Wellington Shields raised shares of DENTSPLY SIRONA from a “hold” rating to a “gradually accumulate” rating in a research note on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and four have assigned a buy rating to the company. The company presently has a consensus rating of “Hold” and a consensus target price of $57.37.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.

See Also: Initial Coin Offering (ICO)

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply